论文部分内容阅读
将38例随机血糖≥20.0mmol/L的2型糖尿病患者随机分为三组,胰岛素泵治疗(CSII)为18例,多次皮下注射胰岛素治疗(MSII)为9例,口服降糖药物治疗11例,进行治疗观察空腹及餐后血糖。结果:CSII组血糖控制达标的天数明显少于MSII组和口服药物组,而且胰岛素的用量明显少于MSII组;CSII组的低血糖发生率较低,并且能满意地控制黎明现象的发生。结论:CSII能明显缩短住院日,是目前2型糖尿病高血糖状态较理想的方法。
Thirty-eight patients with type 2 diabetes who had a random blood glucose≥20.0mmol / L were randomly divided into three groups: insulin pump treatment (CSII) was 18, multiple subcutaneous insulin therapy (MSII) was 9, and oral hypoglycemic drug treatment11 Cases, for treatment of fasting and postprandial blood glucose. Results: The number of days for achieving the goal of glycemic control in CSII group was significantly shorter than that in MSII group and oral drug group, and the dosage of insulin was significantly less than that of MSII group. The incidence of hypoglycemia in CSII group was lower and the occurrence of dawn was satisfactorily controlled. Conclusion: CSII can significantly shorten the hospitalization days, which is the ideal method for hyperglycemia in type 2 diabetes.